BNP Paribas Discount Zert 4AB 30..../ DE000PN58FF2 /
20/08/2024 21:40:16 | Chg.-0.410 | Bid21:45:19 | Ask21:45:19 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
114.600EUR | -0.36% | - Bid Size: - |
- Ask Size: - |
ABBVIE INC. D... | - - | 30/12/2024 | Call |
GlobeNewswire
19/08
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire
15/08
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
09/08
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire
08/08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
07/08
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06/08
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
01/08
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
01/08
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire
01/08
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire
31/07
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire
31/07
Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire
30/07
Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire
28/07
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire
25/07
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...
GlobeNewswire
24/07
Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
GlobeNewswire
24/07
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital